CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
51.76
+2.06 (4.14%)
At close: Apr 8, 2026, 4:00 PM EDT
51.36
-0.40 (-0.77%)
After-hours: Apr 8, 2026, 7:56 PM EDT
CRISPR Therapeutics AG Employees
CRISPR Therapeutics AG had 393 employees as of December 31, 2024. The number of employees decreased by 14 or -3.44% compared to the previous year.
Employees
393
Change (1Y)
-14
Growth (1Y)
-3.44%
Revenue / Employee
$8,931
Profits / Employee
-$1,479,896
Market Cap
4.97B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 393 | -14 | -3.44% |
| Dec 31, 2023 | 407 | -51 | -11.14% |
| Dec 31, 2022 | 458 | -15 | -3.17% |
| Dec 31, 2021 | 473 | 63 | 15.37% |
| Dec 31, 2020 | 410 | 106 | 34.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Apellis Pharmaceuticals | 739 |
| Corcept Therapeutics | 730 |
| Amicus Therapeutics | 511 |
| TG Therapeutics | 399 |
| Xenon Pharmaceuticals | 370 |
| Immunovant | 362 |
| Celcuity | 155 |
CRSP News
- 1 day ago - CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering - GlobeNewsWire
- 4 weeks ago - CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering - GlobeNewsWire
- 7 weeks ago - CRISPR Therapeutics Spotlights Momentum For Lead Gene Therapy As Adoption Widens - Benzinga
- 7 weeks ago - CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 3 months ago - CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones - GlobeNewsWire
- 3 months ago - CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Cathie Wood's Biotech Trend: Twist, Beam, CRISPR Latest Stock Picks - Benzinga